» Authors » Andrew J Mirelman

Andrew J Mirelman

Explore the profile of Andrew J Mirelman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 674
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sittimart M, Rattanavipapong W, Mirelman A, Hung T, Dabak S, Downey L, et al.
Cost Eff Resour Alloc . 2024 May; 22(1):41. PMID: 38741138
The term 'perspective' in the context of economic evaluations and costing studies in healthcare refers to the viewpoint that an analyst has adopted to define the types of costs and...
2.
Footman K, Goel K, Rehnstrom Loi U, Mirelman A, Govender V, Ganatra B
BMJ Glob Health . 2023 Aug; 8(Suppl 4). PMID: 37643800
Introduction: Service inclusion in a country's health benefit package (HBP) is an important milestone towards universal health coverage. This study aimed to explore HBP inclusion of abortion interventions globally. Methods:...
3.
Moler-Zapata S, Kreif N, Ochalek J, Mirelman A, Nadjib M, Suhrcke M
Appl Health Econ Health Policy . 2022 Aug; 20(6):881-891. PMID: 35997895
Background: The marginal productivity of a country's healthcare system refers to the health gains produced per unit change in the level of spending. In budget-constrained settings, this metric reflects the...
4.
Clarke L, Patouillard E, Mirelman A, Ho Z, Edejer T, Kandel N
EClinicalMedicine . 2022 Feb; 44:101269. PMID: 35146401
Background: Investing in health emergency preparedness is critical to the safety, welfare and stability of communities and countries worldwide. Despite the global push to increase investments, questions remain around how...
5.
Rocco L, Fumagalli E, Mirelman A, Suhrcke M
PLoS One . 2021 May; 16(5):e0251424. PMID: 34043654
The question of whether and how changes to population health impact on economic growth has been actively studied in the literature, albeit with mixed results. We contribute to this debate...
6.
Chi Y, Blecher M, Chalkidou K, Culyer A, Claxton K, Edoka I, et al.
Gates Open Res . 2021 Feb; 4:176. PMID: 33575544
Public payers around the world are increasingly using cost-effectiveness thresholds (CETs) to assess the value-for-money of an intervention and make coverage decisions. However, there is still much confusion about the...
7.
Ahmed S, Sarker A, Sultana M, Roth F, Mahumud R, Kamruzzaman M, et al.
BMJ Open . 2020 Mar; 10(3):e030298. PMID: 32132134
Objective: We estimated the effect of an employer-sponsored health insurance (ESHI) scheme on healthcare utilisation of medically trained providers and reduction of out-of-pocket (OOP) expenditure among ready-made garment (RMG) workers....
8.
Ballard S, Tallant A, Guerra R, Quigley D, Stiegmann R, Mirelman A, et al.
Vaccine . 2020 Feb; 38(10):2292-2297. PMID: 32019702
Vaccine implementation planning in low- and middle-income countries (LMIC) often focuses on children without considering special adult populations. We adapted an economic model developed by the United States Department of...
9.
Cuadrado C, Dunstan J, Silva-Illanes N, Mirelman A, Nakamura R, Suhrcke M
Soc Sci Med . 2019 Dec; 245:112708. PMID: 31862547
Chile is one of several countries that recently implemented a fiscal policy to reduce soft drink (SD) intake and obesity. In 2014 the government increased the existing ad-valorem tax on...
10.
Hone T, Mirelman A, Rasella D, Paes-Sousa R, Barreto M, Rocha R, et al.
Lancet Glob Health . 2019 Oct; 7(11):e1575-e1583. PMID: 31607469
Background: Economic recession might worsen health in low-income and middle-income countries with precarious job markets and weak social protection systems. Between 2014-16, a major economic crisis occurred in Brazil. We...